Table 2

Baseline characteristics

Age ≥65 yearsAge <65 yearsP value
(n=245)(n=579)
Demographics and medical history
 Age, years69.2±3.953.7±6.6<0.001
 Female50 (20.4)128 (22.1)0.59
 Caucasian234 (95.5)529 (91.4)*0.04
 Higher education (>13 years)95 (38.8)236 (40.8)0.64
 Relationship (married or cohabiting)198 (80.8)471 (81.3)0.85
Index event
 ST-segment elevation myocardial infarction77 (31.4)266 (45.9)<0.001
 Non-ST-segment elevation myocardial infarction91 (37.1)200 (34.5)0.47
 Unstable angina28 (11.4)40 (6.9)0.04
 Stable angina requiring revascularisation49 (20.0)73 (12.6)0.01
Treatment
 Percutaneous coronary intervention180 (73.5)459 (79.3)0.08
 Coronary artery bypass surgery35 (14.3)52 (9.0)0.03
 Medication only30 (12.2)68 (11.7)*0.82
Medication prescription
 Antiplatelet/anticoagulation agents244 (99.6)578 (99.8)0.51
 Beta-blockers209 (85.3)493 (85.1)1.00
 ACE inhibiter/ARB190 (77.6)423 (73.1)0.19
 Lipid-lowering drugs239 (97.6)559 (96.5)0.52
Previous cardiovascular disease
 Myocardial infarction62 (25.3)121 (20.9)0.17
 Percutaneous coronary intervention49 (20.0)79 (13.6)0.03
 Coronary artery bypass surgery19 (7.8)12 (2.1)<0.001
 Stroke12 (4.9)14 (2.4)0.08
 Peripheral artery disease24 (9.8)15 (2.6)<0.001
No known history of cardiovascular disease134 (54.7)*402 (69.4)<0.001
  • Values are mean±SD or n (%).

  • *Difference between intervention and control group after randomisation, p<0.05.

  • ARB, angiotensin II receptor blockers.